Innovating Works

AdaptVac

A stranger
VICI-DISEASE: PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AN... ADAPTVAC APS participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The enormous health and economic impacts of epidemics and pandemics has become one of the defining public policy and health issues in Europe...
2023-11-13 - 2027-11-30 | financed
ADVANCE-VAC4PM: Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building... ADAPTVAC APS participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Placental malaria (PM) is a severe disease that affects a particularly vulnerable demographic group, pregnant women. The burden of disease i...
2022-05-20 - 2027-05-31 | financed
Prevent-nCoV: Prevention of SARS CoV 2 infection through development and clinical testing of a novel Virus Like Pa... ADAPTVAC APS participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020 Our aim is to perform pre-clinical and clinical evaluation of a potential Wuhan Coronavirus vaccine candidate. The vaccine will be based on...
2020-04-06 - 2022-06-30 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.